Results 291 to 300 of about 111,871 (303)

PARP Inhibitors

2008
openaire   +1 more source

Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy

Cancer Cell, 2019
Daniel J Mcgrail, Chaoyang Sun, Marilyne Labrie   +2 more
exaly  

An update on PARP inhibitors—moving to the adjuvant setting

Nature Reviews Clinical Oncology, 2014
Amir Sonnenblick, Evandro de Azambuja, Hatem A Azim   +2 more
exaly  

PARP and PARP Inhibitor Therapeutics

2013
openaire   +1 more source

The multifaceted roles of PARP1 in DNA repair and chromatin remodelling

Nature Reviews Molecular Cell Biology, 2017
Arnab Ray Chaudhuri
exaly  

Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy

Nature Reviews Clinical Oncology, 2019
Nicola J Curtin, yvette drew
exaly  

Tankyrase-targeted therapeutics: expanding opportunities in the PARP family

Nature Reviews Drug Discovery, 2012
Christopher J Lord
exaly  

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

Cancer Discovery, 2019
Constantia Pantelidou, Olmo Sonzogni, Peter Bouwman   +2 more
exaly  

European regulators approve first PARP inhibitor

Nature Reviews Drug Discovery, 2014
exaly  

PARP inhibitor pick-me-up

Nature Reviews Drug Discovery, 2019
exaly